Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001104659-23-073894

HEAD OF R&D, COO-NOVITIUM OPS sold 40,000 shares at an average $51.75 ($2,070,012)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Shanmugam Muthusamy · HEAD OF R&D, COO-NOVITIUM OPS

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-20 Sale : show line 1 in the form 10b5-1 −14,657 $51.93 $761,138 32,750 D
2023-06-21 Sale : show line 2 in the form 10b5-1 −11,843 $51.95 $615,244 20,907 D
2023-06-22 Sale : show line 3 in the form 10b5-1 −13,500 $51.38 $693,630 7,407 D
Open-market sales · 40,000 sh · avg $51.75 · $2,070,012
Loading xslF345X04/tm2319370-1_4seq1.xml…